Package 0409-2012-32

Brand: buprenorphine hydrochloride

Generic: buprenorphine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0409-2012-32
Digits Only 0409201232
Product NDC 0409-2012
Product ID 0409-2012_37d2deb6-c54a-42bb-ad76-4873a59da562
Description

10 CARTRIDGE in 1 CARTON (0409-2012-32) / 1 mL in 1 CARTRIDGE (0409-2012-03)

Marketing

Marketing Status
Marketed Since 2005-06-14
Brand buprenorphine hydrochloride
Generic buprenorphine hydrochloride
Sample Package No

Linked Drug Pages (1)

Buprenorphine Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "37d2deb6-c54a-42bb-ad76-4873a59da562", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["1655032"], "spl_set_id": ["23aa1bb3-cecf-4e62-29bb-48488bb66fc3"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 CARTRIDGE in 1 CARTON (0409-2012-32)  / 1 mL in 1 CARTRIDGE (0409-2012-03)", "package_ndc": "0409-2012-32", "marketing_start_date": "20050614"}], "brand_name": "Buprenorphine Hydrochloride", "product_id": "0409-2012_37d2deb6-c54a-42bb-ad76-4873a59da562", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0409-2012", "dea_schedule": "CIII", "generic_name": "Buprenorphine Hydrochloride", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine Hydrochloride", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": ".3 mg/mL"}], "application_number": "ANDA074137", "marketing_category": "ANDA", "marketing_start_date": "20050614", "listing_expiration_date": "20261231"}